文献速递神经肌肉病神经免疫

鉴定小窝相关蛋白4自身抗体作为成人免疫介导的波纹肌病生物标志物

Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults.
PubMed 文献 · JAMA Neurol · 2022-01-01

这项回顾性队列研究评估了10例成人免疫介导的波纹肌病(iRMD)患者的存档血清,通过噬菌体免疫沉淀测序鉴定出针对小窝相关蛋白4(cavin-4)的IgG自身抗体,并在8/10例患者中经重组cavin-4免疫分析确认血清阳性,而241例健康及疾病对照均为血清阴性;6例接受免疫治疗的患者中3例症状完全缓解。

要点

  • cavin-4 IgG可能是首个iRMD特异性血清自身抗体生物标志物。
  • 8/10例iRMD患者cavin-4 IgG血清阳性,241例对照均阴性。
  • 6例血清阳性并接受免疫治疗者中3例完全缓解、1例轻度改善、2例无变化。

核心结论

  • cavin-4 IgG可能是iRMD中首个被鉴定的特异性血清自身抗体生物标志物。
  • iRMD患者肌肉活检中cavin-4表达耗竭,提示该自身抗原可能参与疾病发病机制。

研究设计与样本

  • 回顾性队列研究,评估2000年至2021年在梅奥诊所(明尼苏达州罗切斯特)和布莱根妇女医院(马萨诸塞州波士顿)三级诊疗中心经神经肌肉专科医生诊断为iRMD的10例成人患者的存档血清。
  • 采用噬菌体免疫沉淀测序评估血清中共同生物标志物,大多数患者有与iRMD一致的肌肉病理学记录。
  • 中位(范围)随访18(1-30)个月。

主要发现

  • 共鉴定7例男性和3例女性iRMD患者,中位(范围)发病年龄60(18-76)岁。
  • 使用人类蛋白质组噬菌体免疫沉淀测序在iRMD患者血清中鉴定出针对cavin-4的IgG自身抗体,重组cavin-4免疫分析确认8/10例iRMD患者cavin-4 IgG血清阳性。
  • 241例健康及疾病对照(包括重症肌无力和免疫介导性肌病)cavin-4 IgG均为血清阴性。
  • 8例cavin-4 IgG阳性者中6例为男性,中位(范围)年龄60(18-76)岁;初发症状包括下肢肌肉波纹感5/8例或除延髓肌外全部肢体肌肉波纹感2/8例、疲劳9/10例、轻度近端无力3/8例、孤立性肌痛1/8例,随后出现弥漫性波纹感。
  • 所有患者均有叩击诱发的肌肉波纹感,半数有叩击或牵拉诱发的肌肉隆起;4/10例有近端无力;除1例外所有患者血浆肌酸激酶升高;6/10例接受恶性肿瘤筛查,仅1例前瞻性检出癌症。

关键数值与推荐

  • cavin-4 IgG在8/10例iRMD患者中血清阳性,在241例健康及疾病对照中均为血清阴性。
  • 6/6例免疫组化分析标本显示肌膜cavin-4免疫反应性呈镶嵌模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Immune-mediated rippling muscle disease (iRMD) is a rare myopathy characterized by wavelike muscle contractions (rippling) and percussion- or stretch-induced muscle mounding. A serological biomarker of this disease is lacking. OBJECTIVE: To describe a novel autoantibody biomarker of iRMD and report associated clinicopathological characteristics. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated archived sera from 10 adult patients at tertiary care centers at the Mayo Clinic, Rochester, Minnesota, and Brigham & Women's Hospital, Boston, Massachusetts, who were diagnosed with iRMD by neuromuscular specialists in 2000 and 2021, based on the presence of electrically silent percussion- or stretch-induced muscle rippling and percussion-induced rapid muscle contraction with or without muscle mounding and an autoimmune basis. Sera were evaluated for a common biomarker using phage immunoprecipitation sequencing. Myopathology consistent with iRMD was documented in most patients. The median (range) follow-up was 18 (1-30) months. EXPOSURES: Diagnosis of iRMD. MAIN OUTCOMES AND MEASURES: Detection of a common autoantibody in serum of patients sharing similar clinical and myopathological features. RESULTS: Seven male individuals and 3 female individuals with iRMD were identified (median [range] age at onset, 60 [18-76] years). An IgG autoantibody specific for caveolae-associated protein 4 (cavin-4) was identified in serum of patients with iRMD using human proteome phage immunoprecipitation sequencing. Immunoassays using recombinant cavin-4 confirmed cavin-4 IgG seropositivity in 8 of 10 patients with iRMD. Results for healthy and disease-control individuals (n = 241, including myasthenia gravis and immune-mediated myopathies) were cavin-4 IgG seronegative. Six of the 8 individuals with cavin-4 IgG were male, and the median (range) age was 60 (18-76) years. Initial symptoms included rippling of lower limb muscles in 5 of 8 individuals or all limb muscles in 2 of 8 sparing bulbar muscles, fatigue in 9 of 10, mild proximal weakness in 3 of 8, and isolated myalgia in 1 of 8, followed by development of diffuse rippling. All patients had percussion-induced muscle rippling and half had percussion- or stretch-induced muscle mounding. Four of the 10 patients had proximal weakness. Plasma creatine kinase was elevated in all but 1 patient. Six of the 10 patients underwent malignancy screening; cancer was detected prospectively in only 1. Muscle biopsy was performed in 7 of the 8 patients with cavin-4 IgG; 6 of 6 specimens analyzed immunohistochemically revealed a mosaic pattern of sarcolemmal cavin-4 immunoreactivity. Three of 6 patients whose results were seropositive and who received immunotherapy had complete resolution of symptoms, 1 had mild improvement, and 2 had no change. CONCLUSIONS AND RELEVANCE: The findings indicate that cavin-4 IgG may be the first specific serological autoantibody biomarker identified in iRMD. Depletion of cavin-4 expression in muscle biopsies of patients with iRMD suggests the potential role of this autoantigen in disease pathogenesis.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Dubey D, Beecher G, Hammami MB, et al. Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. JAMA Neurol. 2022. PMID: 35696196. doi:10.1001/jamaneurol.2022.1357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。